ValiRx – Final Results

Dr Satu Vainikka, Chief Executive, provides an update on the Company’s portfolio and the progress made for the year ended 31 December 2016. Their clinical trials have performed well and in line with expectations and the Company is looking forward to the next stage of its clinical trials.